Beijing Inno Medicine Co., Ltd.
Clinical trials sponsored by Beijing Inno Medicine Co., Ltd., explained in plain language.
-
New drug aims to treat two conditions at once: heart disease and erectile dysfunction
Disease control Not yet recruitingThis study tests a new medicine called YN001 in 40 people who have both heart or blood vessel disease and erectile dysfunction. The goal is to see if the drug improves erectile function and reduces thickening of the carotid artery. Participants will be randomly assigned to receiv…
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
New drug aims to shrink Heart-Artery plaque in major trial
Disease control Not yet recruitingThis study tests an experimental drug called YN001 in 456 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants will receive either YN001 or a placebo by IV, alongside their usual heart medications. The main goal is to see if YN001 reduces non-calc…
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Healthy volunteers to test experimental heart drug combo
Knowledge-focused Not yet recruitingThis early-stage study will test the safety of a new drug called YN001 when taken with a common cholesterol-lowering medicine (rosuvastatin). Twenty-four healthy Chinese adults will receive the combination and be monitored for side effects. The goal is to gather safety informatio…
Phase: PHASE1 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC